BioNTech acquires German manufacturing site to boost COVID-19 vaccine production

BioNTech acquires German manufacturing site to boost COVID-19 vaccine production

Submitted by admin on September 17, 2020 - 10:48am
Source: 
Biopharma Reporter
News Tags: 
BioNTech
Novartis
Germany
vaccines
MRNA
COVID-19
Headline: 
BioNTech acquires German manufacturing site to boost COVID-19 vaccine production
snippet: 

BioNTech will acquire Novartis’ GMP certified manufacturing facility in Marburg, Germany: with the site set to become one of the largest mRNA manufacturing plants in Europe.

Do Not Allow Advertisers to Use My Personal information